Form 4 for HCA HCA Healthcare
Accepted 2025-09-08 00:00:00 ET · period of report 2025-09-04 · accession 0001632835-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-09-08 | 2025-09-04 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | M - OptEx | $173.12 | +10.9K | 42.4K | +35% | +$1.89M |
| DT | 2025-09-08 | 2025-09-08 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | S - Sale+OE | $418.84 | -3,836 | 31.5K | -11% | -$1.61M |
| DT | 2025-09-08 | 2025-09-04 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | F - Tax | $411.59 | -7,084 | 35.3K | -17% | -$2.92M |
| DT | 2025-09-08 | 2025-09-04 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | M - OptEx | $0.00 | -10.9K | 10.0K | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-04 | M | A | 10,920 | $173.12 | 42,422.90 | D | — | — | (F2) Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans. |
| 2 | Common | Common Stock | 2025-09-08 | S | D | 3,836 | $418.84 | 31,502.90 | D | — | — | (F2) Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans. |
| 3 | Common | Common Stock | 2025-09-04 | F | D | 7,084 | $411.59 | 35,338.90 | D | — | — | (F2) Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans. |
| 4 | Derivative | Stock Appreciation Right | 2025-09-04 | M | D | 10,920 | $0.00 | 10,000 | D | $173.12 · — to 2031-02-03 | 10,920 Common Stock | (F3) The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022. |